Biotoxtech Co., Ltd.

KOSDAQ:A086040 주식 보고서

시가총액: ₩64.7b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Biotoxtech 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Jong-Koo Kang

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권14.4%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

Is Biotoxtech (KOSDAQ:086040) A Risky Investment?

May 06
Is Biotoxtech (KOSDAQ:086040) A Risky Investment?

Estimating The Fair Value Of Biotoxtech Co., Ltd. (KOSDAQ:086040)

Mar 28
Estimating The Fair Value Of Biotoxtech Co., Ltd. (KOSDAQ:086040)

Did Biotoxtech's (KOSDAQ:086040) Share Price Deserve to Gain 91%?

Feb 20
Did Biotoxtech's (KOSDAQ:086040) Share Price Deserve to Gain 91%?

Are Robust Financials Driving The Recent Rally In Biotoxtech Co., Ltd.'s (KOSDAQ:086040) Stock?

Jan 24
Are Robust Financials Driving The Recent Rally In Biotoxtech Co., Ltd.'s (KOSDAQ:086040) Stock?

We're Not So Sure You Should Rely on Biotoxtech's (KOSDAQ:086040) Statutory Earnings

Dec 27
We're Not So Sure You Should Rely on Biotoxtech's (KOSDAQ:086040) Statutory Earnings

Is Biotoxtech (KOSDAQ:086040) Using Too Much Debt?

Nov 30
Is Biotoxtech (KOSDAQ:086040) Using Too Much Debt?

CEO

Jong-Koo Kang (69 yo)

no data

테뉴어

Mr. Jong-Koo Kang, Ph.D. has been the Chief Executive Officer of Biotoxtech Co., Ltd since 2000. Mr. Kang served as the President of Korean Association for Laboratory Animal Science. He was Director-in-Chi...